"Designing Growth Strategies is in our DNA"

Shingles Vaccines Market Size, Share & Industry Analysis, By Type (Recombinant/Conjugate/Subunit and Others), By Product (SHINGRIX and Others), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI102072

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Epidemiology of Shingles (Herpes Zoster)
    2. Reimbursement Scenario, By Key Countries/Regions
    3. Pipeline Analysis, By Key Players
    4. New Product Launches, By Key Players
    5. Key Industry Developments Such as Mergers, Acquisitions, and Partnerships
  5. Global Shingles Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Others
    2. Market Analysis, Insights and Forecast – Product
      1. SHINGRIX
      2. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Shingles Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Others
    2. Market Analysis, Insights and Forecast – Product
      1. SHINGRIX
      2. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Shingles Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Others
    2. Market Analysis, Insights and Forecast – Product
      1. SHINGRIX
      2. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Shingles Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Others
    2. Market Analysis, Insights and Forecast – Product
      1. SHINGRIX
      2. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Shingles Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Others
    2. Market Analysis, Insights and Forecast – Product
      1. SHINGRIX
      2. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Shingles Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Others
    2. Market Analysis, Insights and Forecast – Product
      1. SHINGRIX
      2. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles
      1. GSK plc
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Moderna Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Jiangsu Recbio Technology Co., Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Dynavax Technologies
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Curevo Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Epidemiology of Shingles (Herpes Zoster)
    2. Reimbursement Scenario, By Key Countries/Regions
    3. Pipeline Analysis, By Key Players
    4. New Product Launches, By Key Players
    5. Key Industry Developments Such as Mergers, Acquisitions, and Partnerships
  5. Global Shingles Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Others
    2. Market Analysis, Insights and Forecast – Product
      1. SHINGRIX
      2. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Shingles Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Others
    2. Market Analysis, Insights and Forecast – Product
      1. SHINGRIX
      2. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Shingles Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Others
    2. Market Analysis, Insights and Forecast – Product
      1. SHINGRIX
      2. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Shingles Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Others
    2. Market Analysis, Insights and Forecast – Product
      1. SHINGRIX
      2. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Shingles Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Others
    2. Market Analysis, Insights and Forecast – Product
      1. SHINGRIX
      2. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Shingles Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Others
    2. Market Analysis, Insights and Forecast – Product
      1. SHINGRIX
      2. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles
      1. GSK plc
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Moderna Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Jiangsu Recbio Technology Co., Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Dynavax Technologies
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Curevo Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global Shingles Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032

Figure 2: Global Shingles Vaccines Market Value Share (%), by Type, 2024 & 2032

Figure 3: Global Shingles Vaccines Market Value Share (%), by Product, 2024 & 2032

Figure 4: Global Shingles Vaccines Market Value Share (%), by Distribution Channel, 2024 & 2032

Figure 5: Global Shingles Vaccines Market Value Share (%), by Region, 2024 & 2032

Figure 6: North America Shingles Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 7: North America Shingles Vaccines Market Value Share (%), by Type, 2024

Figure 8: North America Shingles Vaccines Market Value (USD billion), by Product, 2024 & 2032

Figure 9: North America Shingles Vaccines Market Value Share (%), by Product, 2024

Figure 10: North America Shingles Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 11: North America Shingles Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 12: North America Shingles Vaccines Market Value (USD billion), By Country, 2024 & 2032

Figure 13: North America Shingles Vaccines Market Value Share (%), By Country, 2024

Figure 14: Europe Shingles Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 15: Europe Shingles Vaccines Market Value Share (%), by Type, 2024

Figure 16: Europe Shingles Vaccines Market Value (USD billion), by Product, 2024 & 2032

Figure 17: Europe Shingles Vaccines Market Value Share (%), by Product, 2024

Figure 18: Europe Shingles Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 19: Europe Shingles Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 20: Europe Shingles Vaccines Market Value (USD billion), By Country/Sub-Region, 2024 & 2032

Figure 21: Europe Shingles Vaccines Market Value Share (%), By Country/Sub-Region, 2024

Figure 22: Asia Pacific Shingles Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 23: Asia Pacific Shingles Vaccines Market Value Share (%), by Type, 2024

Figure 24: Asia Pacific Shingles Vaccines Market Value (USD billion), by Product, 2024 & 2032

Figure 25: Asia Pacific Shingles Vaccines Market Value Share (%), by Product, 2024

Figure 26: Asia Pacific Shingles Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 27: Asia Pacific Shingles Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 28: Asia Pacific Shingles Vaccines Market Value (USD billion), By Country/Sub-Region, 2024 & 2032

Figure 29: Asia Pacific Shingles Vaccines Market Value Share (%), By Country/Sub-Region, 2024

Figure 30: Latin America Shingles Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 31: Latin America Shingles Vaccines Market Value Share (%), by Type, 2024

Figure 32: Latin America Shingles Vaccines Market Value (USD billion), by Product, 2024 & 2032

Figure 33: Latin America Shingles Vaccines Market Value Share (%), by Product, 2024

Figure 34: Latin America Shingles Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 35: Latin America Shingles Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 36: Latin America Shingles Vaccines Market Value (USD billion), By Country/Sub-Region, 2024 & 2032

Figure 37: Latin America Shingles Vaccines Market Value Share (%), By Country/Sub-Region, 2024

Figure 38: Middle East & Africa Shingles Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 39: Middle East & Africa Shingles Vaccines Market Value Share (%), by Type, 2024

Figure 40: Middle East & Africa Shingles Vaccines Market Value (USD billion), by Product, 2024 & 2032

Figure 41: Middle East & Africa Shingles Vaccines Market Value Share (%), by Product, 2024

Figure 42: Middle East & Africa Shingles Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 43: Middle East & Africa Shingles Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 44: Middle East & Africa Shingles Vaccines Market Value (USD billion), By Country/Sub-Region, 2024 & 2032

Figure 45: Middle East & Africa Shingles Vaccines Market Value Share (%), By Country/Sub-Region, 2024

Figure 46: Global Shingles Vaccines Market Share (%), By Company, 2024

Table 1: Global Shingles Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 2: Global Shingles Vaccines Market Revenue (USD billion) Forecast, by Product, 2019–2032

Table 3: Global Shingles Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 4: Global Shingles Vaccines Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 5: North America Shingles Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 6: North America Shingles Vaccines Market Revenue (USD billion) Forecast, by Product, 2019–2032

Table 7: North America Shingles Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 8: North America Shingles Vaccines Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 9: Europe Shingles Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 10: Europe Shingles Vaccines Market Revenue (USD billion) Forecast, by Product, 2019–2032

Table 11: Europe Shingles Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 12: Europe Shingles Vaccines Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2019-2032

Table 13: Asia Pacific Shingles Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 14: Asia Pacific Shingles Vaccines Market Revenue (USD billion) Forecast, by Product, 2019–2032

Table 15: Asia Pacific Shingles Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 16: Asia Pacific Shingles Vaccines Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2019-2032

Table 17: Latin America Shingles Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 18: Latin America Shingles Vaccines Market Revenue (USD billion) Forecast, by Product, 2019–2032

Table 19: Latin America Shingles Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 20: Latin America Shingles Vaccines Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2019-2032

Table 21: Middle East & Africa Shingles Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 22: Middle East & Africa Shingles Vaccines Market Revenue (USD billion) Forecast, by Product, 2019–2032

Table 23: Middle East & Africa Shingles Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 24: Middle East & Africa Shingles Vaccines Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2019-2032

  • 2019-2032
  • 2024
  • 2019-2023
  • 150
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann